Keeping our insured up to date with emerging clinical risks and our product news.

THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of care plans being fully completed and in place before discharging a patient.

TMLEP Member, Justin Stebbing and his team research Baricitinib as a potential treatment for 2019-nCoV

THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of identifying patients at risk of falls and then managing their time in hospital accordingly.

THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight the importance of recognising red flags of Crohn’s disease, following through with investigations and correctly reviewing tests. Signs of Crohn’s disease must not be ignored, and unexpected results should cause clinicians to consider re-testing or alternate investigations.

TMLEP would highlight the particular litigation risk associated with management of labour and attempted vaginal delivery where abnormalities on CTG trace are not picked up and delivery is not expedited.

THEMIS’ Lead Clinical Partner, TMLEP, would like to highlight how important it is to consider each patient individually and assess the potential risks in light of the individual’s clinical presentation, age, gender and other clinical factors such as test results.